查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1985982

全球神經血管醫療設備市場：市場規模、佔有率和趨勢分析（按器材、治療應用、最終用途和地區分類），基於細分市場的預測（2026-2033 年）

Neurovascular Devices Market Size, Share & Trends Analysis Report By Device, By Therapeutic Applications, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

神經血管醫療設備市場概述

2025年全球神經血管醫療設備市場規模估計為77.8億美元，預計2033年將達到119.1億美元。

預計從 2026 年到 2033 年，該市場將以 5.40% 的複合年成長率成長。推動該市場成長的因素包括神經血管疾病的日益普遍、醫療技術的進步以及人們對微創手術日益成長的興趣。

隨著中風、腦動脈瘤和動靜脈畸形（AVM）等疾病的日益常見，對有效治療方法的需求也隨之成長。中風和動脈瘤等神經血管疾病盛行率的上升是推動市場發展的主要因素。包括血栓切除裝置、微導管和血流導引彈簧圈在內的多種神經血管醫療設備被用來治療這些疾病。根據世界卒中組織（WSO）發布的《2024年全球卒中概況》，每年新增中風病例超過1200萬例，預計全球約有25%的人口在其一生中的某個階段會經歷中風。

中風等神經血管疾病造成的負擔正在顯著增加，預計這將推動對神經血管醫療設備，包括神經血栓切除器械，如血栓切除設備和抽吸裝置。

此外，根據腦動脈瘤基金會2024年8月發布的數據，美國約有680萬人患有未破裂的腦動脈瘤，每年約有3萬人發生腦動脈瘤破裂。因此，神經血管疾病患者數量的激增以及神經血管醫療設備在治療中的日益普及，預計將在未來幾年推動市場成長。

目錄

第1章：分析方法和範圍

第2章執行摘要

第3章：神經血管醫療設備市場：影響因素、趨勢與範圍

  • 市場歷史及展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 神經血管醫療設備分析工具
    • 產業分析：波特五力模型
    • PESTEL 分析

第4章 神經血管醫療設備市場：細分市場分析、器材類型（2021-2033 年）

  • 定義和範圍
  • 市場佔有率分析：按設備類型分類（2025 年和 2033 年）
  • 全球神經血管醫療設備市場：依器材類型分類（2021-2033 年）
  • 市場規模、預測與趨勢分析（2021-2033）

第5章：神經血管醫療設備市場：按治療應用分類的細分市場分析（2021-2033 年）

  • 定義和範圍
  • 市佔率分析：依治療應用分類（2025 年和 2033 年）
  • 全球神經血管醫療設備市場：依治療應用分類（2021-2033 年）
  • 市場規模、預測與趨勢分析（2021-2033）

第6章 神經血管醫療設備市場：依最終用途分類的細分市場分析（2021-2033 年）

  • 定義和範圍
  • 市場佔有率分析：依最終用途分類（2025 年和 2033 年）
  • 全球神經血管醫療設備市場：依最終用途分類（2021-2033 年）
  • 市場規模、預測與趨勢分析（2021-2033）

第7章：神經血管醫療設備市場：區域估算與趨勢分析

  • 區域儀錶板
  • 市場規模、預測與趨勢分析（2021-2033）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 近期趨勢及影響分析：依主要市場參與企業
  • 公司/競爭對手分類
    • 創新者
  • 供應商情況
    • 主要銷售代理商和通路夥伴名單
    • 主要客戶
    • 主要企業：市佔率分析（2025 年）
    • Medtronic
    • Stryker
    • Terumo Corporation
    • Penumbra, Inc.
    • Johnson &Johnson and its affiliates
    • MicroPort Scientific Corporation
    • Acandis GmbH
    • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
    • NeuroSafe Medical Co., Ltd.
    • Rapid Medical
    • Evasc Neurovascular Enterprises
    • Lepu Medical Technology（Beijing）Co., Ltd.
    • phenox GmbH（Wallaby Medical）
  • 公司熱力圖分析/市場分析
  • 企業市場占有率分析（2025 年估計值）
  • 其他主要企業名單
Product Code: GVR-2-68038-851-0

Neurovascular Devices Market Summary

The global neurovascular devices market size was estimated at USD 7.78 billion in 2025 and is projected to reach USD 11.91 billion by 2033, growing at a CAGR of 5.40% from 2026 to 2033. The market is driven by the rising prevalence of neurovascular disorders, advancements in medical technology, and an increasing focus on minimally invasive procedures.

As conditions such as stroke, cerebral aneurysms, and Arteriovenous Malformations (AVM) become more common, the demand for effective treatment options also increases. The increasing prevalence of neurovascular diseases such as strokes and aneurysms is a major driving force behind the market. Various neurovascular devices, including clot retrieval devices, microcatheters, and flow diversion coils, are utilized to treat these conditions. According to the Global Stroke Fact Sheet 2024 published by the World Stroke Organization (WSO), more than 12 million new strokes occur annually, and about 25% of the global population will experience a stroke in their lifetime.

The burden of neurovascular disorders such as strokes is increasing significantly, which is anticipated to propel the demand for neurovascular devices such as neurothrombectomy devices like clot retrievers and suction devices, among others.

In addition, data released by the Brain Aneurysm Foundation in August 2024 indicates that an unruptured brain aneurysm affects an estimated 6.8 million people in the U.S., with around 30,000 individuals suffering a brain aneurysm rupture each year. As a result, the significant number of patients affected by neurovascular diseases and the increasing use of neurovascular devices in their treatment are expected to drive market growth in the coming years.

Global Neurovascular Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global neurovascular devices market report based on device, application, end use, and region:

  • Device Outlook (Revenue USD Million, 2021 - 2033)
  • Cerebral Embolization and Aneurysm Coiling Devices
    • Embolic coils
    • Flow diversion devices
    • Liquid embolic agents
  • Cerebral Angioplasty and Stenting Systems
    • Carotid artery stents
    • Embolic protection systems
  • Neurothrombectomy Devices
    • Clot retrieval devices
    • Suction devices/aspiration catheters
    • Vascular snares
  • Support Devices
    • By Size
    • 0.027"
    • 0.021"
    • 0.071"
    • 0.017"
    • 0.019"
    • 0.013"
    • 0.058"
    • 0.068"
    • Others
    • By Product
    • Micro catheters
    • Micro guidewires
  • Trans Radial Access Devices
  • Therapeutic Application Outlook (Revenue USD Million, 2021 - 2033)
  • Stroke
  • Cerebral Artery
  • Cerebral Aneurysm
    • Aneurysmal Subarachnoid Hemorrhage
    • Others
  • Others
  • End Use Outlook (Revenue USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Others
  • Regional Outlook (Revenue USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Device
    • 1.2.2. Therapeutic Applications
    • 1.2.3. End Use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Neurovascular Devices Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence of Neurovascular Diseases
      • 3.2.1.2. Technological Advancements In Neurovascular Devices
      • 3.2.1.3. Rising Number of Awareness Initiatives
      • 3.2.1.4. Increasing Demand For Minimally Invasive Procedures
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Product Recalls
      • 3.2.2.2. High Treatment Cost Associated With Neurovascular Disorders
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Growing Number of Clinical Trials
      • 3.2.3.2. Launches Of Novel Products
      • 3.2.3.3. Increasing Research & Development Activities
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Shortage of Skilled Professionals
      • 3.2.4.2. Potential Complications & Risks associated with Neurovascular Devices
  • 3.3. Neurovascular Devices Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Neurovascular Devices Market: Segment Analysis, By Device, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Segment Dashboard
  • 4.3. Device Market Share Analysis, 2025 & 2033
  • 4.4. Global Neurovascular Devices Market, by Device, 2021 to 2033
  • 4.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033
    • 4.5.1. Cerebral Embolization and Aneurysm coiling devices
      • 4.5.1.1. Cerebral embolization and aneurysm coiling devices market, 2021 - 2033 (USD Million)
      • 4.5.1.2. Embolic coils
        • 4.5.1.2.1. Embolic coils market, 2021 - 2033 (USD Million)
      • 4.5.1.3. Flow diverters
        • 4.5.1.3.1. Flow diverters market, 2021 - 2033 (USD Million)
      • 4.5.1.4. Liquid embolic agents
        • 4.5.1.4.1. Liquid embolic agents market, 2021 - 2033 (USD Million)
    • 4.5.2. Cerebral angioplasty and stenting systems
      • 4.5.2.1. Cerebral angioplasty and stenting systems market, 2021 - 2033 (USD Million)
      • 4.5.2.2. Carotid Artery Stents
        • 4.5.2.2.1. Carotid artery stents market, 2021 - 2033 (USD Million)
      • 4.5.2.3. Embolic Protection Devices
        • 4.5.2.3.1. Embolic protection systems devices market, 2021 - 2033 (USD Million)
    • 4.5.3. Neurothrombectomy devices
      • 4.5.3.1. Neurothrombectomy devices market, 2021 - 2033 (USD Million)
      • 4.5.3.2. Clot Retrieval Devices
        • 4.5.3.2.1. Clot retrieval devices market, 2021 - 2033 (USD Million)
      • 4.5.3.3. Suction Devices
        • 4.5.3.3.1. Suction devices market, 2021 - 2033 (USD Million)
      • 4.5.3.4. Vascular Snares
        • 4.5.3.4.1. Vascular snares market, 2021 - 2033 (USD Million)
    • 4.5.4. Support devices
      • 4.5.4.1. Support devices market, 2021 - 2033 (USD Million)
      • 4.5.4.2. By Product
        • 4.5.4.2.1. Micro Catheters
          • 4.5.4.2.1.1. Micro catheters market, 2021 - 2033 (USD Million)
        • 4.5.4.2.2. Micro Guidewires
          • 4.5.4.2.2.1. Micro guidewires market, 2021 - 2033 (USD Million)
      • 4.5.4.3. By Size
        • 4.5.4.3.1. 0.027"
          • 4.5.4.3.1.1. 0.027" market, 2021 - 2033 (USD Million)
        • 4.5.4.3.2. 0.021"
          • 4.5.4.3.2.1. 0.021" market, 2021 - 2033 (USD Million)
        • 4.5.4.3.3. 0.071"
          • 4.5.4.3.3.1. 0.071" market, 2021 - 2033 (USD Million)
        • 4.5.4.3.4. 0.017"
          • 4.5.4.3.4.1. 0.017" market, 2021 - 2033 (USD Million)
        • 4.5.4.3.5. 0.019"
          • 4.5.4.3.5.1. 0.019" market, 2021 - 2033 (USD Million)
        • 4.5.4.3.6. 0.013"
          • 4.5.4.3.6.1. 0.013" market, 2021 - 2033 (USD Million)
        • 4.5.4.3.7. 0.058"
          • 4.5.4.3.7.1. 0.058" market, 2021 - 2033 (USD Million)
        • 4.5.4.3.8. 0.068"
          • 4.5.4.3.8.1. 0.068" market, 2021 - 2033 (USD Million)
        • 4.5.4.3.9. Others
          • 4.5.4.3.9.1. Others market, 2021 - 2033 (USD Million)
    • 4.5.5. Trans Radial Access Devices
      • 4.5.5.1. Trans radial access devices market, 2021 - 2033 (USD Million)

Chapter 5. Neurovascular Devices Market: Segment Analysis, By Therapeutic Applications, 2021 - 2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Segment Dashboard
  • 5.3. Therapeutic Applications Market Share Analysis, 2025 & 2033
  • 5.4. Global Neurovascular Devices Market, by Therapeutic Applications, 2021 to 2033
  • 5.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033
    • 5.5.1. Stroke
      • 5.5.1.1. Stroke market, 2021 - 2033 (USD Million)
    • 5.5.2. Cerebral artery stenosis
      • 5.5.2.1. Cerebral artery stenosis market, 2021 - 2033 (USD Million)
    • 5.5.3. Cerebral aneurysm
      • 5.5.3.1. Cerebral aneurysm market, 2021 - 2033 (USD Million)
      • 5.5.3.2. Aneurysmal Subarachnoid Hemorrhage
        • 5.5.3.2.1. Aneurysmal subarachnoid hemorrhage market, 2021 - 2033 (USD Million)
      • 5.5.3.3. Others
        • 5.5.3.3.1. Others market, 2021 - 2033 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others market, 2021 - 2033 (USD Million)

Chapter 6. Neurovascular Devices Market: Segment Analysis, By End Use, 2021 - 2033 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. Segment Dashboard
  • 6.3. End Use Market Share Analysis, 2025 & 2033
  • 6.4. Global Neurovascular Devices Market, by End Use, 2021 to 2033
  • 6.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033
    • 6.5.1. Hospital
      • 6.5.1.1. Hospital market, 2021 - 2033 (USD Million)
    • 6.5.2. Specialty clinics
      • 6.5.2.1. Specialty clinics market, 2021 - 2033 (USD Million)
    • 6.5.3. Others
      • 6.5.3.1. Others market, 2021 - 2033 (USD Million)

Chapter 7. Neurovascular Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Global Key company market share analysis, 2025
    • 8.3.4. Medtronic
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Stryker
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Terumo Corporation
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Penumbra, Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Johnson & Johnson and its affiliates
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. MicroPort Scientific Corporation
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Acandis GmbH
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. NeuroSafe Medical Co., Ltd.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Rapid Medical
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Evasc Neurovascular Enterprises
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Lepu Medical Technology(Beijing) Co., Ltd.
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
      • 8.3.15.4. Strategic initiatives
    • 8.3.16. phenox GmbH (Wallaby Medical)
      • 8.3.16.1. Company overview
      • 8.3.16.2. Financial performance
      • 8.3.16.3. Product benchmarking
      • 8.3.16.4. Strategic initiatives
  • 8.4. Heat Map Analysis/ Company Market Position Analysis
  • 8.5. Estimated Company Market Share Analysis, 2025
  • 8.6. List of Other Key Market Players-

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. North America neurovascular devices market, by country, 2021 - 2033 (USD Million)
  • Table 4. North America neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 5. North America neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 6. North America neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 7. U.S. neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 8. U.S. neurovascular devices, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 9. U.S. neurovascular devices, by end use, 2021 - 2033 (USD Million)
  • Table 10. Canada neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 11. Canada neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 12. Canada neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 13. Mexico neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 14. Mexico neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 15. Mexico neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 16. Europe neurovascular devices market, by country, 2021 - 2033 (USD Million)
  • Table 17. Europe neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 18. Europe neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 19. Europe neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 20. Europe neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 21. UK neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 22. UK neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 23. UK neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 24. Germany neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 25. Germany neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 26. Germany neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 27. France neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 28. France neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 29. France neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 30. Italy neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 31. Italy neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 32. Italy neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 33. Spain neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 34. Spain neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 35. Spain neurovascular devices market, by size, 2021 - 2033 (USD Million)
  • Table 36. Spain neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 37. Norway neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 38. Norway neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 39. Norway neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 40. Sweden neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 41. Sweden neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 42. Sweden neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 43. Denmark neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 44. Denmark neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 45. Denmark neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 46. Asia Pacific neurovascular devices market, by country, 2021 - 2033 (USD Million)
  • Table 47. Asia Pacific neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 49. Asia Pacific neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 50. China neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 51. China neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 52. China neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 53. Japan neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 54. Japan neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 55. Japan neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 56. India neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 57. India neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 58. India neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 59. Australia neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 60. Australia neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 61. Australia neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 62. South Korea neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 63. South Korea neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 64. Thailand neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 65. Thailand neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 66. Thailand neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 67. Thailand neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 68. Latin America neurovascular devices market, by country, 2021 - 2033 (USD Million)
  • Table 69. Latin America neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 70. Latin America neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 71. Latin America neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 72. Brazil neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 73. Brazil neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 74. Brazil neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 75. Argentina neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 76. Argentina neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 77. Argentina neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 78. Middle East & Africa neurovascular devices market, by country, 2021 - 2033 (USD Million)
  • Table 79. Middle East & Africa neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 80. Middle East & Africa neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 81. Middle East & Africa neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 82. South Africa neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 83. South Africa neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 84. South Africa neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 85. Saudi Arabia neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 86. Saudi Arabia neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 87. Saudi Arabia neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 88. UAE neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 89. UAE neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 90. UAE neurovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 91. Kuwait neurovascular devices market, by device, 2021 - 2033 (USD Million)
  • Table 92. Kuwait neurovascular devices market, by therapeutic application, 2021 - 2033 (USD Million)
  • Table 93. Kuwait neurovascular devices market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Neurovascular devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2025)
  • Fig. 10 Segment Outlook
  • Fig. 11 Strategy framework
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Market restraint relevance analysis (Current & future impact)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 17 Neurovascular devices market: Device movement analysis
  • Fig. 18 Neurovascular devices market device outlook: Key takeaways
  • Fig. 19 Cerebral embolization and aneurysm coiling devices market, 2021 - 2033 (USD Million)
  • Fig. 20 Embolic coils market, 2021 - 2033 (USD Million)
  • Fig. 21 Flow diverters market, 2021 - 2033 (USD Million)
  • Fig. 22 Liquid embolic agents market, 2021 - 2033 (USD Million)
  • Fig. 23 Cerebral angioplasty and stenting systems market, 2021 - 2033 (USD Million)
  • Fig. 24 Carotid artery stents market, 2021 - 2033 (USD Million)
  • Fig. 25 Embolic protection systems devices market, 2021 - 2033 (USD Million)
  • Fig. 26 Neurothrombectomy devices market, 2021 - 2033 (USD Million)
  • Fig. 27 Clot retrieval devices market, 2021 - 2033 (USD Million)
  • Fig. 28 Suction devices market, 2021 - 2033 (USD Million)
  • Fig. 29 Vascular snares market, 2021 - 2033 (USD Million)
  • Fig. 30 Support devices market, 2021 - 2033 (USD Million)
  • Fig. 31 Micro catheters market, 2021 - 2033 (USD Million)
  • Fig. 32 Guidewires market, 2021 - 2033 (USD Million)
  • Fig. 33 Size market, 2021 - 2033 (USD Million)
  • Fig. 34 0.027"market, 2021 - 2033 (USD Million)
  • Fig. 35 0.021" market, 2021 - 2033 (USD Million)
  • Fig. 36 0.021" market, 2021 - 2033 (USD Million)
  • Fig. 37 0.071" market, 2021 - 2033 (USD Million)
  • Fig. 38 0.046" market, 2021 - 2033 (USD Million)
  • Fig. 39 0.019" market, 2021 - 2033 (USD Million)
  • Fig. 40 0.013" market, 2021 - 2033 (USD Million)
  • Fig. 41 0.058" market, 2021 - 2033 (USD Million)
  • Fig. 42 0.068" market, 2021 - 2033 (USD Million)
  • Fig. 43 Others market, 2021 - 2033 (USD Million)
  • Fig. 44 Trans radial access devices market, 2021 - 2033 (USD Million)
  • Fig. 45 Neurovascular devices market: Therapeutic application movement analysis
  • Fig. 46 Neurovascular devices market therapeutic applications outlook: Key takeaways
  • Fig. 47 Stroke market, 2021 - 2033 (USD Million)
  • Fig. 48 Cerebral artery stenosis market, 2021 - 2033 (USD Million)
  • Fig. 49 Cerebral aneurysm market, 2021 - 2033 (USD Million)
  • Fig. 50 Aneurysmal subarachnoid hemorrhage market, 2021 - 2033 (USD Million)
  • Fig. 51 Others market, 2021 - 2033 (USD Million)
  • Fig. 52 Others market, 2021 - 2033 (USD Million)
  • Fig. 53 Neurovascular devices market: End use movement analysis
  • Fig. 54 Neurovascular devices market end use outlook: Key takeaways
  • Fig. 55 Hospital market, 2021 - 2033 (USD Million)
  • Fig. 56 Specialty clinics market, 2021 - 2033 (USD Million)
  • Fig. 57 Others market, 2021 - 2033 (USD Million)
  • Fig. 58 Regional outlook, 2025 & 2033
  • Fig. 59 North America neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 60 U.S. neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 61 Canada neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 62 Mexico neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 63 Europe neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 64 UK neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 65 Germany neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 66 France neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 67 Italy neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 68 Spain neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 69 Norway neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 70 Denmark neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 71 Sweden neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 72 Asia Pacific neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 73 Japan neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 74 China neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 75 India neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 76 Australia neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 77 South Korea neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 78 Thailand neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 79 Latin America neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 80 Brazil neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 81 Argentina neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 82 MEA neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 83 South Africa neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 84 Saudi Arabia neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 85 UAE neurovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 86 Kuwait neurovascular devices market, 2021 - 2033 (USD Million)